MoneyWorks4Me

Vineet Laboratories - Quaterly Results

29 Jul 2022 Evaluate
The sales slipped to Rs. 488.22 millions for the June 2022 quarter as against Rs. 576.70 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 10.11  millions from Rs. 12.75 millions ,decline by -20.71%.Operating profit for the quarter ended June 2022 rose to 39.97 millions as compared to 27.54 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 488.22 576.70 -15.34 488.22 576.70 -15.34 1911.72 2434.79 -21.48
Other Income 0.85 0.27 214.81 0.85 0.27 214.81 2.85 3.86 -26.17
PBIDT 39.97 27.54 45.13 39.97 27.54 45.13 135.29 85.31 58.59
Interest 13.66 5.38 153.90 13.66 5.38 153.90 21.68 26.67 -18.71
PBDT 26.31 22.16 18.73 26.31 22.16 18.73 113.61 58.64 93.74
Depreciation 5.42 4.93 9.94 5.42 4.93 9.94 20.16 18.07 11.57
PBT 20.89 17.23 21.24 20.89 17.23 21.24 93.45 40.57 130.34
TAX 10.78 4.48 140.62 10.78 4.48 140.62 27.07 22.78 18.83
Deferred Tax 4.47 0.00 0.00 4.47 0.00 0.00 -4.76 9.99 -147.65
PAT 10.11 12.75 -20.71 10.11 12.75 -20.71 66.38 17.79 273.13
Equity 92.19 92.19 0.00 92.19 92.19 0.00 92.19 92.19 0.00
PBIDTM(%) 8.19 4.78 71.44 8.19 4.78 71.44 7.08 3.50 101.98
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..